US Patent 7968593 Thiolactones
Patent 7968593 was granted and assigned to Eisai on June, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+508 characters)
Article
Patent abstract
This invention provides new compounds, pharmaceutical compositions and diagnostic kits comprising such compounds, and methods of using such compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALADase levels are altered, inhibiting angiogenesis, effecting a TGF-β activity or a neuronal activity, and treating a glutamate abnormality, a compulsive disorder, neuropathy, pain, a prostate disease, cancer, Huntington's disease, diabetes, a retinal disorder or glaucoma.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Barbara S. Slusher0
Takashi Tsukamoto0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07968593 Thiolactones US Patent 7968593 Thiolactones
Infobox
Patent Number
079685930
Patent Number
79685930
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079685930
Date of Patent
June 28, 2011
0Patent Application Number
124722510
Date Filed
May 26, 2009
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07968593 Thiolactones
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07968593
Date of patent
June 28, 2011
Patent application number
12472251
Date Filed
May 26, 2009
Patent primary examiner
Find more entities like US Patent 7968593 Thiolactones
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
